You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
仙琚製藥(002332.SZ):擬掛牌轉讓海盛製藥61.2%股權 聚焦甾體激素主業
格隆匯 01-17 17:38

格隆匯1月17日丨仙琚製藥(002332.SZ)公佈,台州市海盛製藥有限公司(簡稱“海盛製藥”)系公司控股子公司,註冊資本500萬元,公司持有海盛製藥61.2%股權。海盛製藥主營業務為維生素D3原料藥製造,食品添加劑製造等,與公司甾體激素產業鏈不具備協同效應。海盛製藥後續的生產改造、新產品擴充等均需持續投入,具有不確定性。

鑑於上述情況,公司根據發展規劃,聚焦甾體激素主業,公司擬按照國有資產處置程序,通過在產權交易所公開掛牌方式,以不低於標的評估值所對應的股權價值,公開掛牌轉讓公司所持有的海盛製藥61.2%的股權。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account